662 results on '"Luzza, Francesco"'
Search Results
2. Machine Learning Approaches in Inflammatory Bowel Disease
3. Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)
4. Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis
5. Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study.
6. The effects of stress on gut virome: Implications on infectious disease and systemic disorders.
7. The Diagnosis of Wilkie's Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review.
8. Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era
9. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
10. One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1
11. Machine Learning Approaches in Inflammatory Bowel Disease
12. Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa
13. Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
14. Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
15. Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway?
16. Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
17. Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases?
18. Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal Study
19. The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein
20. Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers
21. Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series
22. Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition
23. Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
24. Diagnostic delay in adult coeliac disease: An Italian multicentre study
25. Wide QRS Complex Tachycardia in the Emergency Setting
26. Association between higher duodenal levels of the fructose carrier glucose transporter‐5 and nonalcoholic fatty liver disease and liver fibrosis.
27. Esophageal rupture after Heimlich maneuver: a case report and literature review.
28. How to ‘safely’ manage delivery of a pregnant woman with congenital atrioventricular block?
29. Atrial Fibrillation and QT corrected. What is the best formula to use?
30. Triglyceride-Glucose Index and Hepatic Steatosis Index for the assessment of liver steatosis in HCV patients
31. Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
32. The r’-Wave Algorithm: A New Diagnostic Tool to Predict the Diagnosis of Brugada Syndrome after a Sodium Channel Blocker Provocation Test
33. Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study
34. Diagnostic delay in adult coeliac disease: An Italian multicentre study
35. Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study
36. Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
37. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
38. Case Report: A migrating stitch in a Crohn’s Disease patient
39. Obesity and overweight are linked to increased sodium‐glucose cotransporter 1 and glucose transporter 5 levels in duodenum
40. Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome
41. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015
42. Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial
43. Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy
44. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
45. 954 DILATED CARDIOMYOPATHY AND ATRIOVENTRICULAR BLOCK RELATED TO THE MUTATION IN THE LMNE GENE: DESCRIPTION OF A FAMILY
46. 953 KEY ROLE OF GENETIC ANALYSIS IN A FAMILIAR CASE OF HYPERTROPHIC CARDIAC PHENOTYPE AND VENTRICULAR PREEXCITATION RELATED TO PRKAG2 GENE MUTATION
47. 805 FAILURE OF RYTHMIQ, AN ALGORITHM FAVOURING INTRINSIC CONDUCTION: WHEN IS TOO MUCH OF A GOOD THING?
48. 1026 MYOCARDIAL INFARCTION AND STROKE IN A YOUNG PATIENT AFFECTED BY LES: KEY ROLE OF AN INTEGRATED IMAGING APPROACH
49. 1011 HETEROGENEOUS ARRHYTHMIC PHENOTYPE IN A CASE OF LEFT VENTRICULAR NON COMPACTION CARDIOMYOPATHY
50. 819 PSEUDO-MOBITZ VAGAL ATRIOVENTRICULAR BLOCK: TWO CASE REPORTS IN YOUNG HEALTHY MEN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.